Home › Hemophilia › California › Orange
Hemophilia clinical trials in Orange, CA
4 studies for Hemophilia are looking for participants at sites in and around Orange (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Gene Therapy Study of SPK-8011QQ in Adults With Severe or Moderately Severe Hemophilia A
RecruitingPhase 1/2
- Center for Inherited Blood Disorders, Orange
A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A
RecruitingPhase 3
- Center for Inherited Blood Disorders, Orange
A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B
RecruitingPhase 3
- The Center for Inherited Blood Disorders- Site Number : 8400009, Orange
Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A
RecruitingPhase 1
- The Center for Comprehensive Care and Diagnosis of Inherited Blood Disorders (CIBD), Orange
About Hemophilia
Hemophilia is a rare disorder in which the blood does not clot normally. Usually hemophilia usually occurs in males and is inherited. Learn more.
More about Hemophilia on MedlinePlus
Hemophilia trials in other cities
- Indianapolis, IN8 studies
- Los Angeles, CA7 studies
- Seattle, WA6 studies
- Cedar Rapids, IA6 studies
- Philadelphia, PA5 studies
- Greenville, NC4 studies
- Sacramento, CA4 studies
- Atlanta, GA4 studies
- Little Rock, AR4 studies
- Tampa, FL4 studies
- Dallas, TX4 studies
- Kansas City, MO3 studies
Other studies in Orange
- Non-Small Cell Lung Cancer25 studies
- Metastatic Cancer20 studies
- Colorectal Cancer16 studies
- Ovarian Cancer16 studies
- Pancreatic Cancer15 studies
- Lung Cancer14 studies
- Cancer (all types)14 studies
- Melanoma14 studies
- Prostate Cancer14 studies
- Breast Cancer14 studies
- Liver Cancer (Hepatocellular Carcinoma)14 studies
- Stomach Cancer13 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.